MPO and COVID-19: Enhanced neutrophil activation profiles strongly predict critical COVID-19 illness, and severe patients present with higher plasma levels of neutrophil effectors such as neutrophil extracellular traps (NETs) and granule proteins such as elastase, myeloperoxidase (MPO), and cathepsin (14–16).